Terry Riss, PhD (he/him/his)

Promega Corporation, Wisconsin, United States

Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and held several R&D and Project Management positions since. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Scientific Ambassador, Cell Health involved in outreach educational training activities including validating assay systems applied to 3D cell culture models. Dr. Riss also serves as an editor of the In Vitro Cell-Based Assays section of the Assay Guidance Manual hosted by The National Center for Advancing Translational Sciences (NCATS) at the NIH.

Disclosure information not submitted.

Presentation(s):

• Assay Guidance Workshop for High Throughput Screening and Lead Discovery

  Sunday, February 4, 2024
  8:15 AM – 5:00 PM EST